|
|
|
European Biopharmaceutical Review
|
|
Manuel Silva is a volunteer community health worker in the Peruvian Amazon. His village lies about 20km from the region’s largest city, Iquitos. I met Manuel 10 years ago while working on a malaria control project in his area. He is part of a cadre of volunteer community health workers (CHWs) recruited by the Peruvian Ministry of Health in the mid-1990s to provide malaria case management in remote areas with limited access to health facilities. Like most CHWs in Peru and elsewhere, Manuel is not paid for his work. A subsistence farmer, he spends most of his time tending his crops. He tends to his neighbours’ health when he is not in his fields.
When he first began working as a CHW, Manuel was trained to prepare blood slides for malaria diagnosis. But his training ends there: he can only prepare the slide, not read it. Even if he could read it, there are no microscopes in his village, no stains or reagents – in fact, there’s not even any electricity.
So Manuel has to take the slide to a microscopy-capable health facility. When I first started working with Manuel, the nearest facility with a microscope was about an hour’s walk away, but that facility had no microscopist. The nearest facility with both a microscope and a technician sufficiently trained to use it was another 30 to 40 minutes bus journey. The maths is eye-opening: an hour and a half to the health centre, an hour and a half to get back, add in the wait for the bus and the time to prepare the slide and Manuel has lost half day’s work in the field. This might not be an undue hardship for the occasional patient, but in high transmission season when Manuel sees multiple patients per day and many over the course of a week, leaving the fields daily to transport slides to the nearest microscopy-capable health facility would leave Manuel’s crops in ruin and his family with nothing to eat. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
Steven A Harvey is Senior Malaria Advisor at University Research Co, LLC, and the Center for Human Services, and Principal Investigator of the Diagnostics Cost Analysis for the Developing World study, funded by the Bill & Melinda Gates Foundation to assess developing country diagnostics needs in malaria, HIV/AIDS, tuberculosis, syphilis, gonorrhoea, chlamydia and acute lower respiratory infection. He has 15 years of public health research experience in Africa, Asia, Latin America and the US, and holds a PhD in international health from the Johns Hopkins Bloomberg School of Public Health. |
|
|
|
|
|
 |
News and Press Releases |
 |
Peli BioThermal showcase CoolPall™ Flex and industry leading solutions at Temperature Control and Logistics Conference
Peli BioThermal, the global name in temperature-controlled packaging, is exhibiting its industry leading shipper systems, including its innovative CoolPall™ Flex, at the 19th Annual Cool Chain Temperature Control and Logistics conference.
More info >> |
|
 |
White Papers |
 |
|
Points to Consider When Developing a TMF (Trial Master File) Strategy
Phlexglobal Ltd
Many organizations are currently outsourcing clinical trial activities to one or more contract research organizations (CROs). This strategy enables companies to leverage specialized expertise and take advantage of flexible resourcing throughout the conduct of a clinical trial. Outsourcing minimizes the costs of recruiting experts, building a team and maintaining an infrastructure. However, it can also add complexity as the organization looks to meets its compliance obligations regarding clinical trial documentation.
The documentation referred to in Article 15(5) of Directive 2001/20/EC as the trial master file shall consist of essential documents, which enable both the conduct of a clinical trial and the quality of the data produced to be evaluated.1 This essential study specific documentation is also known as the TMF. As organizations try to minimize their reliance on paper files, the electronic TMF (eTMF) has emerged. A current industry initiative to standardize the organization of this content is known as the TMF Reference Model. This model is helping standardization efforts across paper and electronic systems.
As companies implement outsourcing strategies, CROs and sponsor organizations look for a common foundation on which to build their TMF capabilities. The following paper outlines some of the challenges organizations face when outsourcing clinical trial activities to multiple contract research organizations and a strategy to facilitate partnering and management of trial information between sponsors and CROs.
More info >> |
|
 |
Industry Events |
 |
Formulation and Drug Delivery Series UK
8-9 July 2020, Oxford Global
This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >> |
|
|
